Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone.

Biomedicines · 2022 · PMC9312892 · PMID 35884852

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

dexamethasone (6 mg intravenously) with the standard care, the all-cause 28-day mortality rates were lower in patients treated with methylprednisolone than in those who received dexamethasone, though the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.